- Home
- VRDN vs AIV Comparison
VRDN vs AIV Comparison
Compare VRDN & AIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- AIV
- Stock Information
- Founded
- VRDN 2006
- AIV 1975
- Country
- VRDN United States
- AIV United States
- Employees
- VRDN N/A
- AIV N/A
- Industry
- VRDN Medical Specialities
- AIV Real Estate Investment Trusts
- Sector
- VRDN Health Care
- AIV Real Estate
- Exchange
- VRDN Nasdaq
- AIV Nasdaq
- Market Cap
- VRDN 1.5B
- AIV 1.3B
- IPO Year
- VRDN N/A
- AIV 1994
- Fundamental
- Price
- VRDN $18.13
- AIV $9.00
- Analyst Decision
- VRDN Buy
- AIV
- Analyst Count
- VRDN 12
- AIV 0
- Target Price
- VRDN $36.44
- AIV N/A
- AVG Volume (30 Days)
- VRDN 1.6M
- AIV 1.4M
- Earning Date
- VRDN 02-25-2025
- AIV 02-20-2025
- Dividend Yield
- VRDN N/A
- AIV N/A
- EPS Growth
- VRDN N/A
- AIV N/A
- EPS
- VRDN N/A
- AIV N/A
- Revenue
- VRDN $302,000.00
- AIV $204,735,000.00
- Revenue This Year
- VRDN $2.55
- AIV N/A
- Revenue Next Year
- VRDN N/A
- AIV $6.56
- P/E Ratio
- VRDN N/A
- AIV N/A
- Revenue Growth
- VRDN N/A
- AIV 13.91
- 52 Week Low
- VRDN $11.40
- AIV $7.06
- 52 Week High
- VRDN $27.20
- AIV $9.49
- Technical
- Relative Strength Index (RSI)
- VRDN 44.39
- AIV 57.17
- Support Level
- VRDN $16.60
- AIV $8.56
- Resistance Level
- VRDN $21.58
- AIV $9.17
- Average True Range (ATR)
- VRDN 1.00
- AIV 0.26
- MACD
- VRDN -0.16
- AIV 0.05
- Stochastic Oscillator
- VRDN 30.72
- AIV 82.57
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.
About AIV Apartment Investment and Management Company
Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development and Redevelopment; Operating, and Other. The company generates majority of revenue from operating segment.